How has been the historical performance of Artemis Medicare?

Answer:The historical performance of Artemis Medicare shows a significant upward trend in net sales and profitability over the years, culminating in the fiscal year ending March 2025.

Breakdown:
Artemis Medicare's net sales have steadily increased from 554.80 Cr in March 2022 to 936.92 Cr in March 2025, reflecting a robust growth trajectory. The total operating income followed a similar pattern, rising from 554.80 Cr in March 2022 to 936.92 Cr in March 2025. Operating profit, excluding other income, also saw a notable increase, reaching 151.79 Cr in March 2025, up from 67.45 Cr in March 2022. Profit before tax surged to 107.67 Cr in March 2025, compared to just 37.18 Cr in March 2022, while profit after tax rose to 82.18 Cr from 31.40 Cr in the same period. The company's total assets grew significantly from 709.66 Cr in March 2022 to 1,357.41 Cr in March 2025, indicating strong asset accumulation. Total liabilities also increased, but the company's shareholder's funds more than doubled from 359.42 Cr in March 2022 to 837.68 Cr in March 2025, showcasing improved financial health. Cash flow from operating activities improved to 145.00 Cr in March 2025, up from 59.00 Cr in March 2022, while net cash inflow turned positive at 26.00 Cr in March 2025, compared to a negative outflow of 3.00 Cr in March 2022. Overall, Artemis Medicare has demonstrated significant growth in sales, profits, and financial stability over the past few years.